___

• 1. Vachon F. IVème international congress on tetanus (Dakar 6-11; 1975), Report. Méd Mal Infect 1975; 5,6: 310-11. 1975. 2. UNICEF, WHO. Sustainably eliminating maternal and neonatal tetanus: strategic plan 2012-2015. Available from: www.who.int/immunization/diseases/MNTEStrategicPlan_F.pdf. 3. Dalal S, Samuelson J, Reed J, Yakubu A, Ncube B, Baggaley R. Tetanus disease and deaths in men reveal need for vaccination. Bull World Health Organ 2016; 94 (8):613-21. 4. Tanon AK, Eholie SP, Coulibaly-Dacoury C, et al. [Morbidity and mortality of tetanus in the infectious and tropical diseases department in Abidjan 1985 - 1998]. Bull Soc Pathol Exot 2004; 97(4):283-287. 5. Aba T, Kra O, Ehui E, et al. [Clinical and developmental aspects of care-related tetanus in the reference service of the teaching hospital of Abidjan]. Bull Soc Pathol Exot 2011; 104(1):38-41. 6.Dao S, Oumar AA, Maiga I, Diarra M, Bougoudogo F. [Tetanus in a hospital setting in Bamako, Mali]. Med Trop 2009; 69(5):485-487. 7. Kakou AR, Eholie S, Ehui E, et al. [Localized tetanus in Abidjan: clinical and prognostic features (1976-1997)]. Bull Soc Pathol Exot 2001; 94(4):308-311. 8. Minta DK, Traore AM, Soucko AK, et al. [Mortality and morbidity of tetanus in the infectious diseases department, Point G teaching hospital, in Bamako, Mali (2004-2009)]. Bull Soc Pathol Exot 2012; 105(1):58-63. 9. Soumare M, Seydi M, Ndour CT, Ndour JD, Diop BM. [Epidemiology, clinical features and prognosis of juvenile tetanus in Dakar, Senegal]. Bull Soc Pathol Exot 2005; 98(5):371-373. 10. Sow PS, Seydi M, Diop BM, et al. Facteurs pronostiques du tétanos néonatal à Dakar. Prognosis factors for neonatal tetanus in Dakar. Med Mal Infect 2003; 33 (3):150-154. 11. Scobie HM, Patel M, Martin D, et al. Tetanus Immunity Gaps in Children 5-14 Years and Men ≥15 Years of Age Revealed by Integrated Disease Serosurveillance in Kenya, Tanzania, and Mozambique. Am J Trop Med Hyg 2017; 96(2):415-420. 12. Seydi M, Soumare M, Gbangba-ngai E, et al. [Current aspects of pediatric and adult tetanus in Dakar]. Med Mal Infect. 2005; 35(1):28-32. 13. Yeboue-Kouame BY, Bonny JS, Ahimon E, et al. Étude épidémiologique du tétanos à Abidjan et incidences professionnelles. Archives des Maladies Professionnelles et de Médecine du Travail 1999; 60 (2):132–135. 14. Aba YT, Kra O, Tanoh AC, et al. [Surgical tetanus in Abidjan, Cote d'Ivoire]. Med Sante Trop 2012; 22(3):279-282. 15. Adonis-Koffy LY, Tanon-Ano Bla MJ, N'Guessan R, Eboua TK, Adjaffi Sokolo AE, Timite-Konan AM. [Generalized tetanus with otitic portal of entry after using intra-auricular traditional remedies in a 2 old child]. Bull Soc Pathol Exot 2008; 101(4):301-302. 16. Boumandouki P, Kounkou RY, Teke-Bagamboula JN, Ekouele Mbaki H, Ndinga E. [Intramuscular injections of quinine and tetanus at the Centre Hospitalier Universitaire of Brazzaville, Congo]. Bull Soc Pathol Exot 2008; 101(4):298-300. 17. Ehui E, Kra O, Ouattara I, et al. [Generalized tetanus complicating a traditional medicine applied for snakebite]. Bull Soc Pathol Exot 2007; 100(3):184-185. 18. Ndour CT, Soumaré M, Diop BM, Touré AK, Badiane S. Tetanus in obstetric gateway in Dakar: epidemiological and prognostic aspects about 21 cases observed in the clinic of infectious diseases of the Dakar Teaching Hospital. Med Mal Infect 2002; 32:399-396. 19. Soumare M, Seydi M, Dia NM, et al. [Post-circumcision tetanus in Dakar, Senegal]. Bull Soc Pathol Exot 2008; 101(1):54-57. 20. Ribereau-Gayon R: Tetanus treatment in east African rural area (RD Congo-Zaire). Evaluation of a therapeutic protocol over 21 cases. Med Afr Noire 2000; 47(3):131-138. 21. Hosoglu S, Ayaz C, Faruk Geyik M, Yagmur Y, Faruk Kokoglu O. A continuing problem of tetanus in the southeast of Turkey. Clin Microbiol Infect 1997; 3(6):690-692. 22. Gallais H. [The value of intrathecal administration of antitetanus serum and corticoids in the treatment of manifest tetanus]. Nouvelle Presse Med 1977; 6(18):1571. 23. Kabura L, Ilibagiza D, Menten J, Van den Ende J. Intrathecal vs. intramuscular administration of human antitetanus immunoglobulin or equine tetanus antitoxin in the treatment of tetanus: a meta-analysis. Trop Med Int health. 2006; 11(7):1075-1081. 24. Miranda-Filho Dde B, Ximenes RA, Barone AA, Vaz VL, Vieira AG, Albuquerque VM. Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route. BMJ 2004; 328(7440):615. 25. Wateba M, Diop S, Nichols S, et al. [Intrathecal therapy with 1 500 UI of antitetanic serum and 1.5 g of intravenous metronidazole: prognosis of tetanus in hospitalized patients in Togo]. Sante 2008;18(3):125-129.